The upregulation of these receptors on cancer cells has been suggested as a potential drug target in various cancers—such as GPR68 in head and neck squamous cell cancers, wherein it mediates acid-induced cellular responses including proliferation, invasion, and drug resistance [117]. The gene discussed is GPR68; the disease is cancer.